Top compounds associated with response to SPATA31E1


Feature Type Standardized
Nominal ANOVA
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.089 0.02
mRNA KPT185 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA SN-38 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA AICAR GDSC1000 pan-cancer AAC 0.073 0.02
mRNA tivantinib CTRPv2 pan-cancer AAC 0.1 0.02
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.077 0.02
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.079 0.02
mRNA tivozanib CTRPv2 pan-cancer AAC 0.081 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
Download CSV